Skip to main content
. 2020 May 7;20:86. doi: 10.1186/s12911-020-1100-9

Table 1.

Demographics and clinical outcome of the patients

Variables All included patients
(n = 157)
Alive after 90 days
(n = 111, 70.7%)
Dead in 90 days
(n = 46, 29.3%)
p*
Age (years), mean (SD) 75 (7) 74 (7) 79 (7) < 0.001
Sex, n (%) Female 78 (49.7) 54 (48.6) 24 (52.2) 0.821
Male 79 (50.3) 57 (51.4) 22 (47.8)
Cardiac condition, n (%) No 56 (35.7) 42 (37.8) 14 (30.4) 0.485
Yes 101 (64.3) 69 (62.2) 32 (69.6)
Pulmonary condition, n (%) No 97 (61.8) 70 (63.1) 27 (58.7) 0.740
Yes 60 (38.2) 41 (36.9) 19 (41.3)
Charlson index, mean (SD) 5.91 (2.30) 5.50 (2.12) 6.91 (2.44) < 0.001
median [IQR] 6.00 [4.00, 7.00] 5.00 [4.00, 6.50] 6.00 [5.00, 8.75] 0.001
ASA class, n (%) 1 2 (1.3) 1 (0.9) 1 (2.2) 0.004
2 46 (29.3) 40 (36.0) 6 (13.0)
3 81 (51.6) 57 (51.4) 24 (52.2)
4 27 (17.2) 13 (11.7) 14 (30.4)
5 1 (0.6) 0 (0.0) 1 (2.2)
BMI (kg/m2), median [IQR] 24.5 [21.5, 27.1] 24.6 [21.3, 27.4] 24.4 [22.1, 26.0] 0.713
Heart rate (beats per minute), mean (SD) 87.01 (18.53) 86.71 (18.33) 87.74 (19.17) 0.753
Systolic blood pressure (mmHg), mean (SD) 129.48 (22.31) 132.10 (22.00) 123.17 (22.00) 0.022
Hemoglobin (g/L), mean (SD) 123.64 (22.45) 124.59 (22.32) 121.35 (22.82) 0.412
CRP (mg/L), median [IQR] 63.00 [20.00, 165.00] 58.00 [13.50, 172.00] 98.50 [48.50, 142.75] 0.100
Creatinine (μmol/L), median [IQR] 81.00 [64.00, 121.00] 76.00 [64.00, 114.50] 102.50 [65.25, 139.50] 0.064
Surgery indication, n (%) Ileus/obstruction 92 (58.6) 67 (60.4) 25 (54.3) 0.266
Perforation 37 (23.6) 25 (22.5) 12 (26.1)
Ischaemia 12 (7.6) 6 (5.4) 6 (13.0)
Infection 4 (2.5) 4 (3.6) 0 (0.0)
Bleeding 4 (2.5) 2 (1.8) 2 (4.3)
Other 8 (5.1) 7 (6.3) 1 (2.2)
Number of operations, n (%) 1 109 (69.4) 79 (71.2) 30 (65.2) 0.761
2 35 (22.3) 22 (19.8) 13 (28.3)
3 9 (5.7) 7 (6.3) 2 (4.3)
4 3 (1.9) 2 (1.8) 1 (2.2)
5 1 (0.6) 1 (0.9) 0 (0.0)
Surgical procedure, n (%) Resection with primary anastomosis 64 (40.8) 43 (38.7) 21 (45.7) 0.538
Adhesiolysis 24 (15.3) 19 (17.1) 5 (10.9)
Resection with stoma formation 38 (24.2) 24 (21.6) 14 (30.4)
Other 18 (11.5) 15 (13.5) 3 (6.5)
Primary raphy 10 (6.4) 8 (7.2) 2 (4.3)
Embolectomy without bowel resection 3 (1.9) 2 (1.8) 1 (2.2)
Cancer, n (%) No 78 (49.7) 58 (52.3) 20 (43.5) 0.409
Yes 79 (50.3) 53 (47.7) 26 (56.5)
Blood Transfusion, n (%) No 96 (61.1) 77 (69.4) 19 (41.3) 0.002
Yes 61 (38.9) 34 (30.6) 27 (58.7)
Physiology Score, mean (SD) 23.54 (6.56) 23.62 (5.98) 23.33 (7.86) 0.798
Operative Severity Score (points), mean (SD) 14.73 (2.93) 14.82 (2.79) 14.50 (3.26) 0.535
Morbidity POSSUM, median [IQR] 65.00 [48.80, 82.90] 66.40 [51.20, 82.90] 61.40 [43.08, 86.30] 0.322
Mortality POSSUM, median [IQR] 5.70 [2.80, 13.60] 5.70 [3.05, 12.95] 5.65 [2.50, 16.95] 0.518
Osteopenia, n (%) No 88 (56.1) 71 (64.0) 17 (37.0) 0.003
Yes 69 (43.9) 40 (36.0) 29 (63.0)
Postoperative infection, n (%) No 99 (63.1) 68 (61.3) 31 (67.4) 0.587
Yes 58 (36.9) 43 (38.7) 15 (32.6)
Postoperative heart failure, n (%) No 147 (93.6) 105 (94.6) 42 (91.3) 0.682
Yes 10 (6.4) 6 (5.4) 4 (8.7)
Postoperative MI, n (%) No 146 (93.0) 104 (93.7) 42 (91.3) 0.849
Yes 11 (7.0) 7 (6.3) 4 (8.7)
Postoperative arrhythmia, n (%) No 125 (79.6) 93 (83.8) 32 (69.6) 0.073
Yes 32 (20.4) 18 (16.2) 14 (30.4)
Postoperative renal failure (dialysis), n (%) No 145 (92.4) 106 (95.5) 39 (84.8) 0.049
Yes 12 (7.6) 5 (4.5) 7 (15.2)

* Comparison between the alive and dead patients

ASA, American Society of Anaesthesiology; BMI, body mass index; CRP, C-reactive protein; IQR, interquartile range; SD, standard deviation; MI, myocardial infarction